Curious about the intricate connection between a wealthy family, a potent opioid, and the devastating addiction crisis gripping the United States? Ever wondered how aggressive marketing tactics shaped the narrative around pain management, leading to widespread misuse of a medical breakthrough? Ready to dive into the fascinating and dark history of OxyContin and the Sackler family's controversial role in the opioid epidemic? Begin your journey into the heart of the opioid crisis, tracing the rise and fall of the Sackler empire, from the heights of philanthropy to the depths of legal battles and public condemnation.

Empire of Pain: The Secret History of the Sackler Dynasty

Arthur Sackler emerged from Brooklyn's bustling immigrant backdrop in 1913, embodying the hopes and ambitions of a new generation of Americans. Born to Polish and Galician immigrant parents, Isaac and Sophie Sackler, Arthur quickly shed his old-world name, Abraham, for the more American-sounding Arthur. The Sacklers ran a grocery store and later invested in real estate, moving to the more affluent Flatbush neighborhood.

Arthur's childhood was marked by a fierce protectiveness over his younger brothers, Mortimer and Raymond. Despite the family's financial ups and downs, Arthur thrived academically, starting at Erasmus Hall High School at just twelve, where he was captivated by the Founding Fathers and Thomas Jefferson. He showed early signs of his entrepreneurial spirit, taking on multiple jobs, from selling ads to running a photography business, to support his family.

Arthur's academic journey led him to NYU Medical School just as the Great Depression hit, forcing him to juggle numerous jobs to fund his education and support his family. His tenacity paid off, and he dived into medicine with a passion that extended beyond the classroom, taking on roles from editor to advertising manager.

Post-medical school, Arthur's fascination with psychiatry and mental illness led him to Creedmoor Psychiatric Center. Here, he and his brothers confronted the grim realities of electroshock therapy and lobotomies, both standard yet brutal treatments for mental illness. Determined to find a better way, the Sacklers began experimenting with histamine and published numerous papers on their findings, capturing the media's attention with their revolutionary ideas.

During this period, Arthur met Marietta Lutze, a German doctor struggling to find her footing in post-war America. Their connection was immediate, though complicated by Arthur's existing marriage and family. Despite this, Arthur's relentless pursuit of Marietta, marked by lavish gestures and late-night calls, eventually won her over.

Arthur's life was a whirlwind of medical practice, innovative research, and complex personal relationships. His story is one of unyielding ambition, a quest for knowledge, and the drive to leave a lasting impact on the world.

Who Was Arthur Sackler: The Immigrant's Son Who Revolutionized Psychiatry?

In 1949, a mysterious ad began appearing in medical journals, proclaiming "Terra bona" and hinting at the potential of soil-derived antibiotics to extend human life. Behind this was Pfizer, a company that transitioned from a modest chemical supplier to a major drug producer during WWII, thanks to penicillin. 

However, penicillin wasn’t patented, leading Pfizer to seek other lucrative, patentable drugs. This quest birthed the "miracle drug" era, a time characterized by rapid pharmaceutical innovation and optimism.

Enter Arthur Sackler, a dynamic advertising genius who revolutionized medical marketing while working at William Douglas McAdams. In the 1950s, Sackler deftly marketed Pfizer’s new antibiotic, Terramycin, using bold strategies like teaser ads and employing detail men—polished sales reps who courted doctors with literature and lunches. Sackler's brilliance was in making medical advertising as compelling as consumer goods marketing, ensuring Pfizer and Terramycin became household names.

Sackler's impact was profound; he introduced terms like "broad-spectrum" antibiotics, revolutionizing how drugs were pitched. By 1957, Pfizer's sales force had grown exponentially due to the aggressive marketing of Terramycin.

The 1960s saw another pharmaceutical breakthrough with Roche’s Librium, followed by Valium, both minor tranquilizers developed by chemist Leo Sternbach. These drugs were marketed as solutions for a wide range of ailments, from anxiety to muscle spasms. Sackler’s advertising prowess again shone, with campaigns that suggested these tranquilizers were essential for modern life’s stresses.

Librium and Valium became blockbuster drugs, thanks in part to Sackler’s strategic marketing that blurred the lines between medical necessity and consumer desire. However, their widespread use led to concerns about addiction and abuse. Despite evidence and increasing FDA scrutiny, both Sackler and Roche downplayed these issues, focusing on the drugs' benefits.

Sackler’s influence extended beyond marketing; he launched the Medical Tribune, a newspaper for doctors filled with ads for drugs like Librium and Valium. This venture, while successful, highlighted potential conflicts of interest, as Sackler’s various roles often intersected.

Sackler's legacy is complex. He was a pioneer in medical advertising, but his fortune was built on the aggressive promotion of addictive drugs. Despite critiques and the eventual regulation of these tranquilizers, Sackler maintained they were safe, attributing issues to misuse rather than the drugs themselves.

By the time Valium’s patent expired, it had become the most widely consumed prescription drug, cementing Sackler’s and Roche’s places in pharmaceutical history. Yet, this success was shadowed by the growing recognition of the drugs' addictive potential, a reality that Sackler and Roche were slow to acknowledge. Their story underscores the powerful, often problematic, intersection of medicine, marketing, and profit.

From Soil to Sales: Arthur Sackler, Pfizer, and the Controversial Birth of Modern Medical Advertising

Arthur and Marietta Sackler moved into a Dutch farmhouse on Long Island, quickly realizing they lacked sufficient furniture. Arthur purchased a few pieces from the previous owners, while Marietta brought an antique chest from Germany. They often had to improvise when hosting guests.

Marietta decided to utilize her time at home by installing bookshelves and cabinets. She persuaded Arthur to visit a local cabinetmaker, where Arthur's interest was piqued by a rosewood table. The cabinetmaker mentioned the table's owner, Bill Drummond, a collector of Chinese furniture and a former spy who had lived in China for thirty years.

Arthur's fascination with Chinese art grew after meeting Drummond and buying several pieces from him. This sparked an intense passion in Arthur, who began to collect Chinese antiques with fervor. He studied museum catalogs and volumes on Chinese history, often spending late nights reading scholarly literature.

Arthur's collection grew rapidly, and he formed connections with other collectors, including Paul Singer, a psychiatrist and expert in Asian art. Singer and Arthur shared a deep appreciation for Chinese artifacts, and Singer became a mentor to Arthur.

Arthur's passion for collecting led him to acquire significant pieces and establish relationships with dealers like Mr. Tai. He even managed to purchase a priceless Ch'u Manuscript after persistent negotiations.

Arthur's collection became so extensive that it required private storage spaces. The Sackler home filled with ancient artifacts, sometimes making it difficult for the children to play freely. Despite the challenges, Arthur's passion for collecting provided him a sense of control and comfort, especially as he navigated the complexities of his professional and personal life.

Arthur's collecting mania eventually led to significant public recognition. He donated pieces to museums, including a major gift to the Metropolitan Museum of Art, resulting in the Sackler Wing. This not only brought him public acclaim but also symbolized his quest for immortality through his collection, leaving a lasting legacy.

Did Obsession with Chinese Artifacts Lead to Creation of the Sackler Wing at the Metropolitan Museum of Art?

Arthur's brother, Mortimer Sackler's life was a whirlwind of love, business, and estrangement. His first marriage to the accomplished Muriel Lazarus ended in divorce. Muriel, with degrees from MIT and Columbia, had three children with Mortimer: Ilene, Kathe, and Robert. But in the mid-1960s, Mortimer fell for Gertraud Wimmer, an Austrian art gallery manager half his age, marking a new chapter.

As Purdue Frederick, the pharmaceutical company the Sackler brothers acquired, thrived, Mortimer embraced a European playboy lifestyle. He spent time at the luxurious Hôtel du Cap-Eden-Roc, mingling with jet-setters like novelist Paul Gallico. Despite his success, he was often away, leaving his children behind. His youngest, Bobby, lived with Muriel in Manhattan, while Mortimer and Geri had a daughter, Samantha, in 1968.

Mortimer's European escapades and focus on his "new family" with Geri led to estrangement from his first children. This emotional distance deepened when Mortimer renounced his American citizenship in 1974 to become an Austrian citizen, primarily for tax reasons.

The Sackler brothers' bond, once strong, began to fracture. Arthur, the eldest, felt overshadowed by Mortimer's exploits and resented his brothers' independence. Mortimer and Raymond, the quieter sibling, remained close, but their relationship with Arthur was strained.

A significant rift occurred over the inheritance of IMS, a company originally conceptualized by Arthur but secretly tied to all three brothers and their friend Bill Frohlich. When Frohlich died, Raymond and Mortimer inherited IMS, making millions, while Arthur felt betrayed, receiving nothing.

Tragedy struck when Bobby, struggling with addiction, committed suicide in 1975. Mortimer was devastated, and his marriage to Geri soon ended. He married again, this time to a much younger Englishwoman, Theresa Rowling, with whom he had three children.

Arthur's life, filled with achievements and philanthropy, ended in 1987, leaving a legacy of both remarkable accomplishments and familial discord. His relationships with his brothers were strained until the end, highlighting the complex dynamics within the Sackler family.

Love, Betrayal, and Legacy: The Intricate Saga of Mortimer Sackler and the Pharmaceutical Dynasty

In the spring of 1964, Richard Kapit, a shy freshman at Columbia University, faced a housing dilemma. When a friend suggested rooming with Richard Sackler, son of  Raymond Sackler, Kapit didn't know he was stepping into the world of the affluent Sackler family. 

Both young men hailed from Long Island but from vastly different backgrounds. They secured an apartment at Park West Village, where Kapit got his first glimpse into Sackler’s privileged life—a town house brimming with sturdy, adult furniture.

Their friendship blossomed, with Sackler introducing Kapit to fine wines and exotic Syrian tobacco. Kapit, a modest scholarship student with parents in education and dietary fields, found himself increasingly reliant on Sackler's wealth. Richard Sackler, despite his generosity, seemed to lack empathy, unaware of how his actions affected others.

The summer after their sophomore year, the duo embarked on an unusual project—studying orgasms. Funded by Sackler, they scoured medical libraries and even consulted a neurophysiologist at Woods Hole Oceanographic Institution. Despite the intellectual adventure, tensions over money and Kapit's growing discomfort with Sackler's pressure to lose his virginity strained their relationship. A blow-up over dirty dishes led Kapit to move out, ending their friendship.

Meanwhile, Sackler’s family business, Purdue Frederick, was making waves with products like Betadine and Senokot. Richard's father, Raymond, had high hopes for his son, who later joined the company. Richard’s ambition soon became evident as he spearheaded the development of MS Contin, a groundbreaking morphine pill for cancer pain, which brought Purdue substantial success.

Yet, success came with a ticking clock—the patent cliff. As the patent for MS Contin neared expiration, Purdue needed a successor. Enter OxyContin, a potent opioid based on the Contin time-release system. The idea, attributed to both Richard and his cousin Kathe, promised a lucrative future. But the real challenge was overcoming the stigma of addiction associated with opioids. Purdue aimed to market OxyContin not just for cancer but for a wide range of chronic pain conditions, setting the stage for an ambitious and controversial marketing strategy.

As Purdue Pharma emerged, the Sacklers’ vision extended beyond mere profits. They sought to revolutionize pain management, despite the looming concerns over addiction. This audacious strategy mirrored the family's earlier success with Valium and Librium, aiming to transform a heavy-duty drug into a ubiquitous solution for all pain, setting the stage for both monumental success and profound controversy.

Did Richard Sackler's Ambition Pave the Way for the Opioid Crisis?

The opium poppy, a species of flowering plant, with its delicate beauty, has been a part of human history for thousands of years, revered for its medicinal properties. Ancient civilizations, such as the Mesopotamians and Greeks, discovered that slicing into the poppy's head released a milky paste, later known as opium, which could alleviate pain, induce sleep, and provide a sense of euphoria. However, they also recognized its darker side—dependence and death.

By the 19th century, the British Empire leveraged the lucrative opium trade, leading to wars with China. In Europe, opium's recreational use inspired Romantic poetry, and chemists like Friedrich Sertürner isolated morphine, a potent derivative, naming it after Morpheus, the Greek god of dreams. Morphine became widely used during the American Civil War, resulting in widespread addiction among veterans.

In the early 20th century, the German company Bayer developed heroin, marketing it as a non-addictive alternative to morphine. This was a dangerous misconception, as heroin proved to be even more addictive. Despite early medical enthusiasm, the addictive nature of heroin soon became apparent, and Bayer ceased production in 1913. Yet, the allure of opioids' pain-relieving properties persisted, leading to ongoing challenges in balancing their benefits and risks.

On a rainy April morning in 1995, Calixto Rivera, a worker at the Napp chemical plant in Lodi, New Jersey, reluctantly went to work despite feeling exhausted. The plant, known for its safety violations, was handling volatile chemicals that day. An accident occurred, causing a catastrophic explosion that killed Calixto and four other men, injuring many more. The plant's history of hiring inexperienced workers and its lack of safety measures contributed to the disaster. The Sackler family, owners of Napp, distanced themselves from any responsibility, showing no public remorse.

In 1996, Purdue Pharma launched OxyContin, a controlled-release opioid, with great fanfare. Richard Sackler, driven by ambition, envisioned OxyContin revolutionizing pain management. Purdue's sales force, incentivized by uncapped bonuses, aggressively marketed the drug, emphasizing its supposed low risk of addiction. They targeted general practitioners and regions with high rates of chronic pain, urging doctors to prescribe OxyContin for moderate to severe pain.

Despite early concerns about OxyContin's addictive potential, Purdue promoted it as a safe and effective solution. The company's marketing strategy included sponsoring seminars, distributing promotional materials, and providing free samples. Sales soared, making OxyContin a blockbuster drug, but reports of abuse and addiction soon followed.

Investigative reporter Barry Meier of The New York Times received a tip about OxyContin abuse in early 2001. He discovered that Purdue Pharma's aggressive marketing had downplayed the drug's addictive potential, leading to widespread misuse. Despite internal warnings and mounting evidence of abuse, Purdue and the Sacklers continued to defend OxyContin, blaming the abusers rather than the drug.

Amid growing scrutiny, Purdue's sales tactics and the Sacklers' reluctance to address the addiction crisis came under fire. Richard Sackler's dismissive attitude towards addicts and the company's focus on profits over public safety highlighted the darker side of OxyContin's success. The story of OxyContin's rise and the resulting epidemic of addiction became a cautionary tale of corporate greed and the devastating impact of opioid abuse.

Morpheus' Legacy: The Dark History of Opioids from Ancient Times to the OxyContin Epidemic

On a late summer day in 2001, a small Pennsylvania town became the epicenter of a heated debate about the opioid crisis. A U.S. House subcommittee, led by Congressman James Greenwood, convened to discuss the havoc wreaked by OxyContin. This potent painkiller, produced by Purdue Pharma, had swept through communities, leaving addiction and despair in its wake.

At the hearing, representatives from Purdue—Michael Friedman, Howard Udell, and Paul Goldenheim—presented a well-rehearsed narrative. They claimed OxyContin was a lifeline for millions suffering from chronic pain, emphasizing that these patients were neither addicts nor criminals. But behind the facade, Purdue's aggressive marketing tactics were becoming increasingly evident.

Richard Sackler, the elusive head of Purdue, avoided the spotlight, delegating public appearances to Friedman, Udell, and Goldenheim. These men traveled extensively, defending OxyContin and countering claims that the drug was being widely abused. Their testimonies were consistent, but investigations revealed a darker truth.

Internal company documents and sales rep notes painted a grim picture. Despite Purdue's assertions, they knew OxyContin was being abused almost from the start. Sales reps were encouraged to downplay addiction risks and push high doses, even when doctors expressed concerns about the drug's street value.

As the crisis deepened, Purdue faced mounting legal challenges. John Brownlee, a U.S. Attorney in Virginia, took a keen interest in Purdue's practices. His team unearthed damning evidence, leading to a criminal investigation. Despite intense pressure from Purdue's high-powered legal team, Brownlee pushed for felony charges.

The case culminated in 2007, when Purdue and its executives pleaded guilty to misbranding charges. The company paid a $600 million fine, and Friedman, Udell, and Goldenheim received probation and hefty fines. Yet, the Sackler family, who owned Purdue, remained unscathed, continuing to profit from OxyContin sales.

This saga highlights the devastating impact of corporate greed and the complex interplay between big pharma, law enforcement, and public health. Despite the guilty plea, Purdue's operations continued, underscoring the challenges of holding powerful entities accountable in the face of widespread addiction and suffering.

Did Purdue Pharma Know About the Opioid Crisis Sooner Than They Admitted?

Imagine a string of uninhabited coral islands, a hidden gem in the Caribbean that has become the playground for the super-rich. Turks and Caicos, nestled between the Bahamas and the Dominican Republic, offers a unique blend of powdery sands and crystal-clear waters, embodying the ultimate Robinson Crusoe seclusion. 

It's no wonder celebrities like Brad Pitt and David Beckham have been spotted vacationing there. One of the most luxurious resorts, Amanyara, epitomizes this opulence, with nightly rates reaching up to $10,000 and private residences fetching up to $20 million.

Into this paradise stepped Mortimer Sackler Jr., the eldest son of the infamous Mortimer Sackler of Purdue Pharma. Raised amidst Manhattan’s elite, Mortimer Jr. enjoyed a life marked by extravagance, attending prestigious schools like Dalton and Harvard. He married Jacqueline Pugh, and together they built a life of luxury, vacationing at exclusive spots like Cap d’Antibes and owning sprawling estates in the Hamptons and Manhattan.

The Sackler family's wealth, however, came from a dark source: OxyContin. Purdue Pharma’s aggressive marketing of this opioid led to a catastrophic epidemic. Even after a guilty plea for misleading the public about the drug's addictive properties, the family continued to advocate for the drug. At the same time, Mortimer Jr. and his wife found solace in their Amanyara retreat, complete with a personal chef and a staff-to-guest ratio of five to one.

Purdue’s attempt to mitigate the crisis came in 2010 with a reformed, "abuse-deterrent" version of OxyContin. Though hailed as a scientific marvel, the timing was telling. The reformulation coincided with the original patent's expiration, a tactic known as "evergreening" to prolong profitability. While the new pills were harder to abuse by crushing, they did little to stop the growing tide of opioid addiction.

As the reformulated OxyContin made it harder for users to get their high, many turned to a cheaper and more accessible alternative: heroin. This transition marked the beginning of a new crisis. By 2010, the U.S. was in the throes of a full-blown heroin epidemic, with many users having started on prescription opioids like OxyContin. The Sackler family, meanwhile, distanced themselves from this grim reality, focusing on philanthropy and maintaining their luxurious lifestyle.

The transition from OxyContin to heroin was starkly evident in the data. Studies showed that a significant number of new heroin users had initially been hooked on prescription painkillers. The reformulation of OxyContin, intended to curb abuse, inadvertently fueled a shift to heroin, exacerbating the opioid crisis.

The story of Mortimer Sackler Jr. and his family's legacy is a cautionary tale of wealth built on the suffering of millions, juxtaposed against the backdrop of their opulent lifestyles. Their story serves as a reminder of the devastating consequences of prioritizing profit over people.

From Opioid Profits to Paradise: The Sackler Family's Luxurious Lifestyle Amidst a Nationwide Crisis

The only Sackler to spend time behind bars was Madeleine, Richard Sackler’s niece. Madeleine grew up in a bohemian, intellectual household in Greenwich, Connecticut, where her father, Jonathan, was deeply involved in the charter school movement. Jonathan’s passion for education reform inspired Madeleine, who went on to study biopsychology at Duke before falling in love with filmmaking.

In 2010, she released "The Lottery," a documentary about charter schools in Harlem, which was well-received and even shortlisted for an Academy Award. During her work on this film, Madeleine’s interest shifted to the American prison system, leading her to make "O.G.," a fictional film grounded in reality by being filmed inside the Pendleton Correctional Facility. This film starred both professional actors like Jeffrey Wright and actual inmates, including Theothus Carter, and was later acquired by HBO.

While making "O.G.," Madeleine simultaneously created a documentary, "It’s a Hard Truth, Ain’t It," about life inside Pendleton, which garnered an Emmy nomination. Her compelling storytelling earned her the Bill Webber Award for Community Service.

However, Madeleine's work was shadowed by her family's connection to Purdue Pharma and the opioid crisis. Despite her advocacy for social justice, she avoided discussing her family’s role in the epidemic. Purdue’s OxyContin had devastated many communities, including Indiana, where she filmed her prison documentaries. 

The Sackler family, including Madeleine's father Jonathan, actively reaped profits from the opioid crisis while maintaining a polished public image through philanthropy and clever PR tactics to keep their name out of negative stories.

Madeleine’s reluctance to address her family's involvement with Purdue led to criticism, particularly from those like Jeffrey Wright, who felt that her lack of transparency tainted her work. Meanwhile, the Sacklers continued to face escalating legal and public scrutiny over their role in the opioid epidemic, culminating in a significant but ultimately insufficient settlement with Kentucky, which led to sealed records and continued controversy.

Is Madeleine Sackler's Cinematic Success Overshadowed by Her Family's Opioid Crisis Involvement?

In 2016, renowned photographer Nan Goldin was dividing her time between Berlin, Paris, and New York. Goldin, often seen with her signature cigarette, had captured raw, intimate moments for half a century. Her work was shaped by personal tragedy, including her sister Barbara's suicide when she was just eleven. This loss drove Nan to leave home at fourteen and find solace in photography, capturing the fringes of society.

Goldin's life took another dark turn during the AIDS crisis, losing many friends to the disease. She chronicled their deaths through her lens, but her own struggle with heroin addiction began in the 1970s. After years of on-and-off use, she finally entered rehab in 1988, emerging sober to find her community ravaged by AIDS. In 2014, while in Berlin, she was prescribed OxyContin for severe tendinitis, leading to a new addiction.

Three years vanished as Goldin battled this addiction, eventually overdosing on fentanyl-laced heroin. Frightened, she entered rehab again in 2017. While recovering, she read about the Sackler family, owners of Purdue Pharma, the makers of OxyContin, and their role in the opioid crisis.

Galvanized, Goldin launched PAIN (Prescription Addiction Intervention Now), targeting Sackler-funded cultural institutions. She and her group staged dramatic protests, like tossing pill bottles into the Met's reflecting pool and unfurling banners at the Guggenheim, demanding accountability from the Sacklers.

These actions led several prestigious institutions, including the Guggenheim and the Tate, to sever ties with the Sacklers. Goldin's relentless activism, combined with mounting legal battles against Purdue Pharma, brought unprecedented scrutiny to the family. Her campaign underscored the devastating human cost of the opioid crisis and the moral responsibility of those who profited from it.

Nan Goldin: From Behind the Lens to the Frontlines of the Opioid Crisis

When Joss Ruggles, the daughter of a Canadian diplomat, met David Sackler, son of Richard Sackler, she perceived him as a finance guy. A linguistics graduate from CUNY, Joss had a fascination with intrigue and no intention of being a mere trophy wife. She founded LBV, a club for wealthy women that transformed into a fashion brand. Despite her attempts to carve out her own identity, the shadow of the Sackler family's association with Purdue Pharma and the opioid crisis loomed large.

Meanwhile, Maura Healey, the relentless Attorney General of Massachusetts, spearheaded the legal battle against Purdue Pharma, determined to hold the Sacklers accountable for the devastation wrought by OxyContin. Alongside her deputy, Joanna Lydgate, and with evidence amassed from Purdue’s internal documents, Healey aimed to expose the Sacklers' direct involvement in the crisis. Purdue's lawyers, including Mary Jo White, fought back, but the tide of public and legal scrutiny was relentless.

Joss's attempts to distance herself from the family’s pharmaceutical empire were futile. Whether launching her LBV fashion line or attending swanky events, she couldn't escape the scrutiny. Maura Healey's lawsuit, bolstered by findings from a trove of documents, implicated the family deeply, revealing their extensive and invasive control over Purdue.

Meanwhile, Purdue Pharma faced bankruptcy under the watchful eye of Judge Robert Drain, who temporarily shielded the Sacklers from further lawsuits. The family proposed transforming Purdue into a public trust, a move seen by many as an attempt to retain their fortune while dodging accountability. The COVID-19 pandemic complicated matters further, exacerbating the opioid crisis and delaying proceedings.

In a dramatic turn, members of the Sackler family were summoned to testify before Congress. David Sackler expressed sorrow but denied wrongdoing, a stance that rang hollow against the backdrop of testimonies from affected families. Despite their wealth and influence, the Sacklers couldn’t escape the growing condemnation from society and institutions alike.

Public pressure mounted as cultural and educational institutions began severing ties with the Sacklers, removing their names from buildings and programs. Nan Goldin, an artist and activist, along with others, led protests demanding the removal of the Sackler name from prominent places like the Louvre and Harvard.

As the legal and public battles continued, the Sacklers clung to their narrative of innocence, but the relentless pursuit of truth by figures like Maura Healey ensured their legacy would be forever tarnished. The once-vaunted family name, synonymous with philanthropy, became a symbol of greed and devastation, leaving a lasting impact on society’s fight against the opioid crisis.

Can the Sackler Family Evade Accountability for the Opioid Crisis?

Arthur Sackler's journey is a compelling story of ambition and innovation, beginning in Brooklyn as the son of Polish and Galician immigrants. His early life was marked by academic excellence and entrepreneurial endeavors, leading him to NYU Medical School during the Great Depression. Arthur's passion for psychiatry and mental illness drove him to Creedmoor Psychiatric Center, where he sought alternatives to the harsh treatments of electroshock therapy and lobotomies, eventually turning to histamine research.

Arthur's ingenuity extended to the pharmaceutical industry, where he revolutionized medical advertising. His work with Pfizer's Terramycin and later Librium and Valium for Roche showcased his talent for making medical advertising compelling and effective. However, his aggressive promotion of these drugs blurred the lines between medical necessity and consumer desire, leading to widespread use and subsequent addiction concerns.

Arthur also had a deep passion for collecting Chinese art, which provided comfort and a sense of control amidst his professional and personal complexities. His collection grew rapidly, leading to significant public recognition and donations to major museums, symbolizing his quest for immortality through his legacy.

The Sackler family's story is also one of internal discord and estrangement, particularly between Arthur and his brothers, Mortimer and Raymond. Mortimer's European lifestyle and focus on his "new family" led to estrangement from his first children, while the brothers' business dealings caused further rifts.

Richard Sackler, Arthur's nephew, played a pivotal role in Purdue Pharma's development of OxyContin, a potent opioid that promised revolutionized pain management but led to a devastating addiction crisis. Purdue's aggressive marketing downplayed addiction risks, resulting in widespread misuse and legal battles. The Sacklers, despite their wealth and philanthropy, faced mounting scrutiny and condemnation for their role in the opioid epidemic.

The Sackler family's legacy is complex, marked by significant contributions to medicine and art but overshadowed by the ethical implications of their business practices and the profound impact of the opioid crisis. Their story underscores the powerful intersection of medicine, marketing, and profit, and the lasting consequences of corporate greed.

Home

Trending

Collections

Key Ideas & Notes

Insights

Highlights & Bookmarks

Listening History